Venlor SR (Venlafaxine Extended-Release): Uses, Dosage, Safety and Interactions

Venlor SR is a prescription antidepressant containing venlafaxine, a serotonin and norepinephrine reuptake inhibitor (SNRI). It is used as part of an individual treatment plan when a clinician determines that venlafaxine is appropriate. Patients with a valid prescription may buy Venlor SR through a properly licensed pharmacy; the medicine should not be started, shared, or substituted without prescriber oversight. Venlor SR price can vary with the prescribed strength, pack size, pharmacy, and insurance or local dispensing arrangements, but cost should never determine a dose change.

Venlafaxine affects chemical signaling involved in mood and anxiety symptoms. Response is individual and may take time to assess. Continued follow-up is important, particularly early in treatment and after a dose adjustment, because the prescriber needs to evaluate benefit, tolerability, mood changes, blood pressure, and any new medicines. Venlor SR is not a medication for immediate relief of a crisis. Seek urgent help for thoughts of self-harm, severe agitation, or a sudden dangerous change in behavior.

Indications

Extended-release venlafaxine products are used for major depressive disorder and generalized anxiety disorder. Depending on the specific approved product and jurisdiction, venlafaxine extended-release may also be used for social anxiety disorder or panic disorder. A clinician should confirm the indication for the particular Venlor SR presentation before treatment. Depression and anxiety can have overlapping medical, medication-related, and psychosocial causes, so this medicine is not a substitute for a full clinical assessment.

Venlor SR is not established as a routine treatment for diabetic neuropathy or fibromyalgia simply because a person has pain symptoms. Do not use it for an unapproved purpose without a clinician who can assess alternatives, coexisting conditions, and potential risks. Children, adolescents, young adults, and families should be advised that antidepressants can be associated with increased suicidal thoughts and behaviors in younger patients; close monitoring and prompt reporting of mood or behavior changes are essential.

Dosage

Take Venlor SR exactly as prescribed, generally once daily with food when using an extended-release product. Swallow the dosage form whole with water unless the approved product instructions specifically say otherwise; do not crush, chew, divide, or dissolve an extended-release tablet or capsule. The starting dose, timing, and any gradual increase depend on the condition being treated, treatment response, adverse effects, age, liver function, kidney function, and other medicines. A missed dose should be taken when remembered unless it is close to the next scheduled dose; do not double a dose.

Available strengths may include 37.5 mg, 75 mg, and 150 mg, although supply and dosage forms differ by market. Patients with a valid prescription can buy Venlor SR 37.5 mg when that strength matches the clinician’s planned initiation or taper. Patients may buy Venlor SR 75 mg only when it is the prescribed strength and formulation. A patient may buy Venlor SR 150 mg when the prescriber has selected that strength as part of an individualized regimen. Venlor SR price should be checked against the exact prescribed strength and release type to avoid dispensing errors.

Do not stop Venlor SR abruptly unless emergency medical care directs otherwise. Stopping too quickly can cause discontinuation symptoms, including dizziness, nausea, headache, sweating, sleep disturbance, anxiety, irritability, sensory disturbances, or flu-like symptoms. If treatment needs to end, the prescriber will usually develop a gradual taper and may adjust it according to symptoms. Contact the prescriber before making any change, including a change prompted by side effects or cost.

Safety Information

Do not take Venlor SR if you have had a serious hypersensitivity reaction to venlafaxine, desvenlafaxine, or a component of the product. It must not be used with a monoamine oxidase inhibitor (MAOI) or within the required washout periods because of the risk of potentially life-threatening serotonin syndrome. Tell the prescriber about bipolar disorder or mania, seizures, glaucoma or eye-risk factors, heart disease, hypertension, bleeding problems, low sodium, kidney or liver disease, pregnancy, breastfeeding, and all past medication reactions.

Venlafaxine can raise blood pressure and pulse. Blood pressure should be controlled before therapy when elevated and monitored before and regularly during treatment. Common effects can include nausea, dry mouth, sweating, constipation, reduced appetite, dizziness, insomnia, fatigue, tremor, sexual adverse effects, and changes in weight. Some effects improve with time, but persistent or troublesome symptoms warrant medical advice rather than self-adjustment.

Get urgent medical care for chest pain, fainting, seizure, severe allergic symptoms, unusual bleeding, black stools, severe confusion, or symptoms of serotonin syndrome such as agitation, fever, fast heartbeat, sweating, diarrhea, rigid muscles, tremor, or loss of coordination. Eye pain, blurred vision, redness, or swelling around the eye needs urgent assessment because angle-closure glaucoma can occur in susceptible people. Alcohol and activities requiring alertness may be unsafe until the person knows how Venlor SR affects them.

Interactions

MAOIs are contraindicated with Venlor SR. At least 14 days should generally separate stopping an MAOI and starting venlafaxine, and at least 7 days should generally separate stopping venlafaxine and starting an MAOI; the prescriber must direct any transition. This includes MAOI activity associated with medicines such as linezolid and intravenous methylene blue in relevant clinical settings.

Other serotonergic medicines can increase the risk of serotonin syndrome, including SSRIs, other SNRIs, triptans, tricyclic antidepressants, lithium, buspirone, certain opioids, amphetamines, tryptophan, and St. John’s wort. Aspirin, NSAIDs, antiplatelet drugs, and anticoagulants may increase bleeding risk. Some medicines can alter venlafaxine exposure or compound effects on blood pressure, heart rhythm, sedation, or alertness. Give the prescriber and pharmacist a complete, current list of prescription medicines, nonprescription products, vitamins, and herbal supplements.

Patients obtaining Venlor SR should use a pharmacy that verifies the prescription, strength, formulation, and interaction profile. Venlor SR price is only one practical consideration; it does not replace pharmacist counseling or clinical monitoring. Never combine, stop, or switch antidepressants on your own.

Medical disclaimer: This content is for informational purposes only and does not replace advice, diagnosis, or treatment from a licensed healthcare professional. It is not a substitute for the approved product information or emergency care. Patients should follow their prescriber’s directions and consult their healthcare professional about personal medical decisions, symptoms, medicines, and treatment changes.